Literature DB >> 2945572

The atrial natriuretic factor.

J Genest.   

Abstract

In less than three years since the rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats was reported the factor responsible for the diuretic, natriuretic, and vasodilating activity of the atrial homogenates was isolated, its chemical structure elucidated, and its total synthesis achieved. Also the cDNA and the gene encoding for the atrial natriuretic factor in mice, rats, and man have been cloned and the chromosomal site identified. The major effects of this hormone are vasodilatation, prevention and inhibition of the contraction induced by noradrenaline and angiotensin II, diuresis, and natriuresis associated in most instances with a pronounced increase in glomerular filtration rate and filtration fraction, inhibition of aldosterone secretion, and considerable stimulation of particulate guanylate cyclase activity. High density specific binding sites have been demonstrated in the zona glomerulosa of the adrenal cortex, in the renal glomeruli, and in the collecting ducts, and in the brain areas involved in the regulation of blood pressure and of sodium and water (AV3V region, subfornical organ, nucleus tractus solitarius, area postrema).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945572      PMCID: PMC1236863          DOI: 10.1136/hrt.56.4.302

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  104 in total

1.  Renal effects of a synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized dogs.

Authors:  T Yukimura; K Ito; T Takenaga; K Yamamoto; K Kangawa; H Matsuo
Journal:  Eur J Pharmacol       Date:  1984-08-17       Impact factor: 4.432

2.  ANF-like peptide(s) in the peripheral autonomic nervous system.

Authors:  W Debinski; J Gutkowska; O Kuchel; K Racz; N T Buu; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1986-01-14       Impact factor: 3.575

3.  Effect of atrial natriuretic factor [ANF (Arg 101--Tyr 126)] on kallikrein and cyclic GMP in the renovascular hypertensive rat.

Authors:  R Garcia; G Thibault; P Hamet; J Gutkowska; M Cantin; J Genest
Journal:  Clin Exp Hypertens A       Date:  1985

4.  Raised circulating levels of atrial natriuretic peptides in essential hypertension.

Authors:  G A Sagnella; N D Markandu; A C Shore; G A MacGregor
Journal:  Lancet       Date:  1986-01-25       Impact factor: 79.321

5.  Molecular cloning and characterization of DNA sequences encoding rat and human atrial natriuretic factors.

Authors:  R A Zivin; J H Condra; R A Dixon; N G Seidah; M Chrétien; M Nemer; M Chamberland; J Drouin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay.

Authors:  I Tanaka; K S Misono; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1984-10-30       Impact factor: 3.575

7.  Effects of synthetic atrial natriuretic factor on renal function and renin release.

Authors:  J C Burnett; J P Granger; T J Opgenorth
Journal:  Am J Physiol       Date:  1984-11

8.  Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa.

Authors:  A De Léan; J Gutkowska; N McNicoll; P W Schiller; M Cantin; J Genest
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

9.  Blood levels and renal effects of atrial natriuretic peptide in normal man.

Authors:  P Weidmann; L Hasler; M P Gnädinger; R E Lang; D E Uehlinger; S Shaw; W Rascher; F C Reubi
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  Lack of a direct effect of atrial natriuretic factor in the rabbit proximal tubule.

Authors:  M Baum; R D Toto
Journal:  Am J Physiol       Date:  1986-01
View more
  11 in total

1.  Concepts of neuroendocrine cardiology and neuroendocrine immunology, chemistry and biology of signal molecules.

Authors:  Armen Galoyan
Journal:  Neurochem Res       Date:  2010-11-03       Impact factor: 3.996

Review 2.  Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea.

Authors:  Laura H White; T Douglas Bradley
Journal:  J Physiol       Date:  2012-12-10       Impact factor: 5.182

3.  Is atrial natriuretic peptide really a hormone?

Authors:  R J Linden; M F Knapp
Journal:  Br Heart J       Date:  1986-10

4.  Plasma concentrations of atrial natriuretic peptide in patients with artificial and transplanted hearts.

Authors:  G Deray; G Maistre; P Cacoub; A Carayon; P Leger; J Rottembourg; M Anouar; P Sassano; C Cabrol
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].

Authors:  T Eisenhauer; J Talartschik; E Quentin; W Kreutzfeldt; F Scheler
Journal:  Klin Wochenschr       Date:  1988-09-15

6.  Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies.

Authors:  S Rocco; G Opocher; D D'Agostino; L Leone; F Mantero
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

7.  A comparative study of groups by age for the intra- and postoperative water and electrolyte management of oesophageal carcinoma.

Authors:  Y Kojima; Y Hiramatsu; A Nakagawa; M Nishi; K Hioki; M Yamamoto
Journal:  Jpn J Surg       Date:  1990-09

8.  Atrial natriuretic factor in patients with acromegaly.

Authors:  G Deray; P Chanson; G Maistre; A Warnet; J Eurin; C Barthelemy; F Masson; F Martinez; J Lubetzki; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.

Authors:  B Lettgen; M Bald; H Valleé; K E Bonzel; W Rascher
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

10.  Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitus.

Authors:  E Jungmann; M C Walter-Schräder; T Haak; W Fassbinder; G Wambach; P H Althoff; K Schöffling
Journal:  Klin Wochenschr       Date:  1988-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.